Skip to main content

Nikki Buchmayer Named to the MM+M Women to Watch 2026 Class

Nikki Buchmayer, Senior Vice President, Digital, cultivated her rich global perspective early on. Nikki’s parents emigrated from the Soviet Union, and with Russian as their primary language, she gained a deep appreciation for the nuances of language, culture and the role of communications in bridging divides. This lived experience has become the bedrock of her career, distinguishing Nikki as an up-and-coming leader and inspiring her recent recognition by MM+M as a 2026 Woman to Watch. The MM+M Women to Watch award, now in its 11th year, celebrates healthcare marketing executives and leaders who are making an outsized impact on their companies and the industry.

Joining GCI Health in 2019, Nikki swiftly ascended to her current role as Senior Vice President. Demonstrating an innate ability to connect with clients coupled with a masterful command of digital strategies, Nikki has had a measurable impact on GCI Health — building global consistency and effectiveness for the agency’s digital communications strategies. Nikki has also been instrumental in accelerating growth for GCI Health’s Clinical Trial Communications practice. A featured speaker at the SCOPE Clinical Trials Summit 2026, Nikki is also quickly emerging as an industry thought leader.

“Nikki’s unique blend of global insights and cultural fluency has been instrumental in creating our award-winning Clinical Trial Recruitment practice,” says Kristin Cahill, Global CEO, GCI Group. “Her solid leadership, commitment to health equity and pursuit of innovative digital solutions for our clients around the world make her a true MM+M Woman to Watch.”

Read more about the MM+M Women to Watch here.